Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Primorus Inv. Share News (PRIM)
PRIM Share
Price
PRIM Share
News
PRIM Share
Chat
PRIM Share
Trades
PRIM
Live RNS
PRIM Share
Charts
PRIM Level 2
Console
PRIM Live
Share Price
PRIM Broker
Ratings
PRIM Directors
Deals
PRIM Financial
Diary
PRIM
Fundamentals
PRIM Short
Positions
PRIM
Media
PRIM Company
Research
PRIM Company
Timeline
Share Price Information for Primorus Inv. (PRIM)
Last checked at -
Last checked at 
Intraday Primorus Inv. Share Chart
Primorus Inv. News
EARNINGS AND TRADING: Everplay pushes back Hell Let Loose release date
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...
Primorus Investments posts smaller full-year profit
(Sharecast News) - Primorus Investments reported a lower full-year profit for 2025, although net assets rose as the investment company said it had mad...
TRADING UPDATES: Cordel teams with TFL; SDI expects results in line
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
EARNINGS AND TRADING: Genedrive fundraise; Real Estate moves to profit
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...
Pri0r1ty Intelligence threatens litigation after Primorus sells shares
(Alliance News) - Pri0r1ty Intelligence Group PLC on Monday said it was investigating whether a recent share disposal by Primorus Investments PLC brea...
AIM WINNERS & LOSERS: Pennant inks Siemens deal; Ariana readies mine
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.
LONDON BRIEFING: DCC sells unit; South32 warns of Mozal impairment
(Alliance News) - DCC announced a deal to sell a part of its technology arm for GBP100 million, GSK is pursuing US approval for expanded use of its RS...
Follow the stocks
